Find research datasets worth reusing

closedIPD-NOFeb 2026View details →

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

ClinicalTrials.gov study NCT02573493. IPD Sharing: NO. Countries: 1. Publications: 1.

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

ClinicalTrials.gov study NCT01156142. IPD Sharing: Not stated. Countries: 1. Publications: 1.

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

ClinicalTrials.gov study NCT00409565. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

ClinicalTrials.gov study NCT02383927. IPD Sharing: UNDECIDED. Countries: 10. Publications: 1.

Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer

ClinicalTrials.gov study NCT00358007. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

ClinicalTrials.gov study NCT00705016. IPD Sharing: Not stated. Countries: 9. Publications: 1.

A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer

ClinicalTrials.gov study NCT02085460. IPD Sharing: Not stated. Countries: 1. Publications: 2.

Zalutumumab in Head and Neck Cancer

ClinicalTrials.gov study NCT00093041. IPD Sharing: Not stated. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →

WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer

ClinicalTrials.gov study NCT03028766. IPD Sharing: YES. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

ClinicalTrials.gov study NCT03101514. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →

Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer

ClinicalTrials.gov study NCT00064298. IPD Sharing: NO. Countries: 1. Publications: 1.

Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

ClinicalTrials.gov study NCT00266279. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma

ClinicalTrials.gov study NCT02325401. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Everolimus Versus Placebo in Head and Neck Cancer

ClinicalTrials.gov study NCT01111058. IPD Sharing: Not stated. Countries: 1. Publications: 1.

publicMar 2023View details →

dryad36/100

Data for: HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer

Open the record for dataset details and reuse information.

opennotspecifiedJan 2009View details →

Distribution. Angola, DR Congo, Malawi, Mozambique, Tanzania, and Zambia. Description. Head-body 46:5-47-8 cm (males), 44-45-5 cm (females), tail 40-43 cm (males), 38-39 cm (females), hindfoot 8:7-9-8 cm (males), 8-9 cm (females), ear 4-7-5-4 cm (males), 5-1-5-8 cm (females); weight 1-3-2 kg. The coat color is pale ocher, with brownish or grayish tones; melanistic individuals are quite common. The throat and chest are blackish, and the ventral pelage varies from creamy white to dirty white. The stripes and spots on the body vary from different hues of brown to black. The nuchal stripes run as two parallel lines from the nape to the shoulders, where they diverge and enlarge towards the elbows; they are not so conspicuously marked as in other genet species. Below them, a pair of thinner stripes and small spots are scattered on the shoulders and sides of the neck. A third pair of thinner, parallel stripes runs down the neck between the nuchal stripes, extending to about one fourth of the mid-dorsal line, where they vanish or diverge as the first row of flank spots. The black mid-dorsal line is continuous and is flanked on each side by four rows of oblong to squared spots, and by a few small-scattered spots below. There is a dorsal erectile crest. The face has a dark mask and a pair of white sub-ocular spots. The tail has seven to nine black rings, alternating with pale rings; the intervening white spaces are pigmented with a brownish tinge on the dorsal midline. The width of the pale rings relative to the dark rings in the middle of the tail is 50-75%; the tip of the tail is dark. The hindlimbs and forelimbs are black; there are white hairs on the metacarpals and metatarsals. [he posterior parts of the feet are dark. There are two pairs of teats. The posterior chamber of the auditory bulla is not ventrally inflated and has a continuous curve line on the external side. The ratio between the inter-orbital constriction and frontal width is 1-00 + 0-12. Dental formula: 13/3, C1/1,P 4/4, M 2/2 = 40. in Viverridae

Distribution. Angola, DR Congo, Malawi, Mozambique, Tanzania, and Zambia. Description. Head-body 46:5-47-8 cm (males), 44-45-5 cm (females), tail 40-43 cm (males), 38-39 cm (females), hindfoot 8:7-9-8 cm (males), 8-9 cm (females), ear 4-7-5-4 cm (males), 5-1-5-8 cm (females); weight 1-3-2 kg. The coat color is pale ocher, with brownish or grayish tones; melanistic individuals are quite common. The throat and chest are blackish, and the ventral pelage varies from creamy white to dirty white. The stripes and spots on the body vary from different hues of brown to black. The nuchal stripes run as two parallel lines from the nape to the shoulders, where they diverge and enlarge towards the elbows; they are not so conspicuously marked as in other genet species. Below them, a pair of thinner stripes and small spots are scattered on the shoulders and sides of the neck. A third pair of thinner, parallel stripes runs down the neck between the nuchal stripes, extending to about one fourth of the mid-dorsal line, where they vanish or diverge as the first row of flank spots. The black mid-dorsal line is continuous and is flanked on each side by four rows of oblong to squared spots, and by a few small-scattered spots below. There is a dorsal erectile crest. The face has a dark mask and a pair of white sub-ocular spots. The tail has seven to nine black rings, alternating with pale rings; the intervening white spaces are pigmented with a brownish tinge on the dorsal midline. The width of the pale rings relative to the dark rings in the middle of the tail is 50-75%; the tip of the tail is dark. The hindlimbs and forelimbs are black; there are white hairs on the metacarpals and metatarsals. [he posterior parts of the feet are dark. There are two pairs of teats. The posterior chamber of the auditory bulla is not ventrally inflated and has a continuous curve line on the external side. The ratio between the inter-orbital constriction and frontal width is 1-00 + 0-12. Dental formula: 13/3, C1/1,P 4/4, M 2/2 = 40.

opencc-by-4.0Dec 2021View details →

Electrochemotherapy as Palliative Treatment in Patients with Recurrent and/or Metastatic Head and Neck Tumours: Features Analysis for an Early Determination of the Partial Responsive Patients

We uploaded the data of enrolled patients in the manuscript "Electrochemotherapy as Palliative Treatment in Patients with Recurrent and/or Metastatic Head and Neck Tumours: Features Analysis for an Early Determination of the Partial Responsive Patients"

opencc-by-4.0Sep 2022View details →

Raw datasets and media accompanying the manuscript: Fused Raman spectroscopy analysis of blood and saliva delivers high accuracy for head and neck cancer diagnostics

Raw datasets and media accompanying the manuscript: Fused Raman spectroscopy analysis of blood and saliva delivers high accuracy for head and neck cancer diagnostics

opencc-by-4.0Aug 2024View details →

Head Neck CBCT CT datasets

Planning CT images were acquired using the Brilliance CT Big Bore Scanner (Phillips Medical Systems, Andover, MA). Each CT image data includes 90-176 slices with a thickness of 3mm, and each slice has 512×512 voxels with a resolution of 1.1719 mm. Multiple CBCT images were acquired using an onboard Imager (OBI, Varian Medical Systems, Palo Alto, CA) in full-fan mode by Varian Edge linear accelerator during treatment, but only the images obtained on the first treatment day were used in this study. Each CBCT data contains 88 slices with a thickness of 3mm. Each slice has 270×270 voxels with a resolution of 1mm. All the scans have ground truth segmentations, each of which contains 5 anatomical structures. To keep the same spatial resolution between CT images and CBCT images, we resampled the CT image to a resolution of 1 mm×1 mm×3 mm. Both CT and CBCT images contain extraneous information, such as background regions, shoulder regions, and treatment beds. Thus, we cropped all CT and CBCT images to a standardized size and removed any irrelevant information within the field of view (FOV) to ensure that the images shared a consistent receptive field that covered only the head-neck region of interest. The final CT and CBCT images contain 240×240×64 voxels with a resolution of 1 mm×1 mm×3 mm.